• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

Bristol-Myers Squibb Company BMY 3 Star

Last Price$65.00Day Change (%)0.46%
Open Price$64.56Day Change ($)0.30
Day Range64.15–65.5252-Week Range46.30–69.20

As of Thu 3/26/2015 5:44:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Bristol-Myers Squibb Sets Pay for Incoming, Retiring CEOs

    Bristol-Myers Squibb Sets Pay for Incoming, Retiring CEOs

  2. FDA approves Bristol-Myers Squibb's Opdivo to treat lung cancer

    FDA approves Bristol-Myers Squibb's Opdivo to treat lung cancer

  3. Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC®, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

    Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVACĀ®, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

  4. Correction to Bristol-Myers Squibb CEO Pay Article on Friday

    Correction to Bristol-Myers Squibb CEO Pay Article on Friday

  5. Why Apple isn't among Morgan Stanley's favorite big stocks

    Why Apple isn't among Morgan Stanley's favorite big stocks

  6. UPDATE: Why Apple isn't among Morgan Stanley's favorite big stocks

    UPDATE: Why Apple isn't among Morgan Stanley's favorite big stocks

  7. Merck Increases Buyback Authorization by $10 Billion

    Merck Increases Buyback Authorization by $10 Billion

  8. Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi Dominating

    Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi Dominating

  9. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.